Chugai Pharmabody Research (CPR) is a subsidiary of Chugai Pharmaceutical in Japan, a member of Roche group, dedicated to addressing unmet medical needs through antibody drug discovery using proprietary technologies.
Headquarters:
Singapore
Company Type:
MNC / Large Enterprise
Company size:
51-200 Employees
Year Founded:
2012 (14 years)
Address:
3 BIOPOLIS DR; #07 -11 TO 16; SINGAPORE, SINGAPORE 138623, SG
At a glanceThe company has a sophisticated ownership structure and may be part of a large corporate group
The company's annual budgeting is likely to take place between October - December
HIGH
spending power
